These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8035397)

  • 21. Renal excretion of urate in normal and gouty subjects at high, normal and low plasma urate levels.
    Fontenaille C; Guiheneuc P; Heron B; Prost A; Lucas J
    Biomedicine; 1974 Sep; 21(9):382-5. PubMed ID: 4457158
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnostic value of renal urate excretion].
    Häntzschel U; Költzsch V
    Z Gesamte Inn Med; 1978 Mar; 33(6):180-4. PubMed ID: 645153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered fractional excretion of uric acid during total parenteral nutrition.
    Derus CL; Levinson DJ; Bowman B; Bengoa JM; Sitrin MD
    J Rheumatol; 1987 Oct; 14(5):978-81. PubMed ID: 3123676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-level lead exposure, renal function and blood pressure.
    Staessen J
    Verh K Acad Geneeskd Belg; 1995; 57(6):527-74. PubMed ID: 8686371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical aspects and renal function in patients with endemic nephropathy].
    Bukvić D; Djukanović L; Janković S
    Srp Arh Celok Lek; 2003; 131(1-2):10-6. PubMed ID: 14608855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-level lead exposure and the prevalence of gout: an observational study.
    Krishnan E; Lingala B; Bhalla V
    Ann Intern Med; 2012 Aug; 157(4):233-41. PubMed ID: 22910934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.
    Sundy JS; Ganson NJ; Kelly SJ; Scarlett EL; Rehrig CD; Huang W; Hershfield MS
    Arthritis Rheum; 2007 Mar; 56(3):1021-8. PubMed ID: 17328081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
    Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
    J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.
    Perez-Ruiz F; Atxotegi J; Hernando I; Calabozo M; Nolla JM
    Arthritis Rheum; 2006 Oct; 55(5):786-90. PubMed ID: 17013833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders.
    Puig JG; Torres RJ; de Miguel E; Sánchez A; Bailén R; Banegas JR
    Metabolism; 2012 Apr; 61(4):512-8. PubMed ID: 22001332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperuricemia, hypertension, and proteinuria associated with high-altitude polycythemia.
    Jefferson JA; Escudero E; Hurtado ME; Kelly JP; Swenson ER; Wener MH; Burnier M; Maillard M; Schreiner GF; Schoene RB; Hurtado A; Johnson RJ
    Am J Kidney Dis; 2002 Jun; 39(6):1135-42. PubMed ID: 12046023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible renal insufficiency, hyperuricemia and gouty arthritis in a case of hypothyroidism.
    Mooraki A; Bastani B
    Clin Nephrol; 1998 Jan; 49(1):59-61. PubMed ID: 9491289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum urate and gout in a young male workforce (author's transl)].
    Zalokar J; Lellouch J; Claude JR
    Pathol Biol (Paris); 1980 Sep; 28(7):441-7. PubMed ID: 6999429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serum urate and gout in 4663 young male workers (author's transl)].
    Zalokar J; Lellouch J; Claude JR
    Sem Hop; 1981 Apr 8-15; 57(13-14):664-70. PubMed ID: 6264615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precocious familial gout with reduced fractional urate clearance and normal purine enzymes.
    Calabrese G; Simmonds HA; Cameron JS; Davies PM
    Q J Med; 1990 May; 75(277):441-50. PubMed ID: 2388995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum urate and renal function in different forms of hypercalcemia.
    Lind L; Ljunghall S
    Exp Clin Endocrinol; 1992; 99(2):87-90. PubMed ID: 1639124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of lead exposure, serum uric acid and parameters of renal function in Nigerian lead-exposed workers.
    Alasia DD; Emem-Chioma PC; Wokoma FS
    Int J Occup Environ Med; 2010 Oct; 1(4):182-90. PubMed ID: 23022807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purine metabolism in patients with gout: the role of lead.
    Miranda-Carús E; Mateos FA; Sanz AG; Herrero E; Ramos T; Puig JG
    Nephron; 1997; 75(3):327-35. PubMed ID: 9069456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does renal impairment protect from gout?
    Youssef P; Brama T; York H; Pickard P; Stewart P; McGill N
    J Rheumatol; 1995 Mar; 22(3):494-6. PubMed ID: 7783068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.